Online citations, reference lists, and bibliographies.
← Back to Search

Radionuclides Delivery Systems For Nuclear Imaging And Radiotherapy Of Cancer.

M. Hamoudeh, M. A. Kamleh, R. Diab, H. Fessi
Published 2008 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The recent developments of nuclear medicine in oncology have involved numerous investigations of novel specific tumor-targeting radiopharmaceuticals as a major area of interest for both cancer imaging and therapy. The current progress in pharmaceutical nanotechnology field has been exploited in the design of tumor-targeting nanoscale and microscale carriers being able to deliver radionuclides in a selective manner to improve the outcome of cancer diagnosis and treatment. These carriers include chiefly, among others, liposomes, microparticles, nanoparticles, micelles, dendrimers and hydrogels. Furthermore, combining the more recent nuclear imaging multimodalities which provide high sensitivity and anatomical resolution such as PET/CT (positron emission tomography/computed tomography) and SPECT/CT (combined single photon emission computed tomography/computed tomography system) with the use of these specific tumor-targeting carriers constitutes a promising rally which will, hopefully in the near future, allow for earlier tumor detection, better treatment planning and more powerful therapy. In this review, we highlight the use, limitations, advantages and possible improvements of different nano- and microcarriers as potential vehicles for radionuclides delivery in cancer nuclear imaging and radiotherapy.
This paper references
10.1016/J.IJPHARM.2004.08.010
Steady-state fluorescence study on release of camptothecin from agar hydrogel.
J. Liu (2004)
10.1053/SONC.2002.31672
Radioembolization for hepatic metastases.
M. Herba (2002)
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipies.
A. Hendlisz (2006)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1016/J.IJROBP.2003.10.057
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
L. Li (2004)
10.1021/BP060208+
Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers.
Shuliang Li (2007)
10.1097/01.RVI.0000161142.12822.66
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
R. Murthy (2005)
10.1023/A:1013569329846
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.
B. Gray (2001)
10.1038/bjc.1991.124
Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model.
H. Yanagië (1991)
10.3748/WJG.V11.I26.4003
Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel.
Q. Wang (2005)
10.1097/01.RVI.0000179815.44868.66
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
R. Lewandowski (2005)
10.1016/S0939-6411(01)00198-9
In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
Futoshi Shikata (2002)
10.1021/BC015557Y
Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy.
X. Q. Pan (2002)
10.1148/92.7.1453
Radioactive albumin microspheres for studies of the pulmonary circulation.
B. Rhodes (1969)
10.1016/0883-2897(89)90014-7
Gallium-68-labeled macroaggregated human serum albumin, 68Ga-MAA.
G. A. Even (1989)
An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
D. Emfietzoglou (2001)
10.1016/S1748-0132(07)70083-X
Targeted nanoparticles for cancer therapy
F. Gu (2007)
10.1016/S0168-3659(03)00242-6
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies.
S. Dagar (2003)
10.1016/J.ADDR.2005.09.014
Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
A. Patri (2005)
10.1016/0168-3659(95)00165-4
Introduction of cisplatin into polymeric micelle
M. Yokoyama (1996)
10.1016/S0969-8043(99)00093-7
Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy.
G. Wunderlich (2000)
10.1007/s00259-005-0007-0
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution
S. Ballot (2005)
10.1002/MRM.1910080111
Gadolinium‐labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver
G. Kabalka (1988)
10.1111/j.1600-0609.1987.tb01438.x
In vitro and in vivo behavior of 111In‐labelled platelets: An experimental study of healthy male volunteers
H. Wadenvik (1987)
10.1097/00006231-198604000-00002
Animal studies on the in vivo stability of 211At‐labelled albumin particles
G. Wunderlich (1986)
Rapid tumor imaging by active background reduction using biotin-bearing liposomes and avidin.
I. Ogihara-Umeda (1994)
10.2307/3579303
Alterations in the progression of cells through the cell cycle after exposure to alpha particles or gamma rays.
D. Gadbois (1996)
10.1158/1535-7163.MCT-05-0161
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
M. Backer (2005)
10.1016/J.IJPHARM.2004.09.022
Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles.
Tanima Banerjee (2005)
10.1007/BF02897257
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice
N. Chiannilkulchai (2008)
10.3109/08982109409018621
Uptake of yttrium-90 into lipid vesicles
D. Utkhede (1994)
10.1097/00006123-200102000-00022
Intratumoral Arteriovenous Shunting in Malignant Gliomas
L. Mariani (2001)
10.1016/S0360-3016(98)00554-9
Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
U. Häfeli (1999)
10.1054/bjoc.1999.1232
Biodistribution and pharmacokinetics of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
K. Harrington (2000)
10.1016/J.APRADISO.2004.03.114
Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy.
Zhang Chun-fu (2004)
10.1124/jpet.102.039669
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting
I. Brigger (2002)
10.1007/s002590000293
Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity
Hisataka Kobayashi (2000)
In vivo evaluation of 111In-labeled T-lymphocyte homing in experimental colitis.
C. van Montfrans (2004)
10.1208/aapsj060323
Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies
L. H. Reddy (2008)
Comparison of In-111-labeled platelets and iodinated fibrinogen for the detection of deep vein thrombosis.
L. Knight (1978)
10.1053/SNUC.2001.26205
Evolution of Tc-99m in diagnostic radiopharmaceuticals.
S. Banerjee (2001)
Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.
M. Yokoyama (1990)
10.1016/J.ADDR.2005.09.017
Dendrimers in gene delivery.
C. Dufès (2005)
10.1016/0090-8258(92)90140-E
Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice.
I. Vergote (1992)
10.1016/S0169-409X(98)00093-3
Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis.
Cutler (1999)
10.1021/BC950077Q
Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors.
J. Capala (1996)
10.1002/ijc.22581
Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles
G. Hu (2007)
10.1016/J.JCONREL.2004.01.002
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
M. Oyewumi (2004)
10.1016/0005-2736(95)00283-9
Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography.
N. Oku (1996)
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.
A. Gabizon (1990)
10.1016/S0142-9612(01)00309-X
Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres.
J. F. Nijsen (2002)
10.1016/J.APRADISO.2004.11.003
Labeling and biodistribution of different particle materials for radioembolization therapy with 188Re.
G. Wunderlich (2005)
Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
N. Sato (2001)
Radionuclide angiography to predict patient response to hepatic artery chemotherapy.
W. Kaplan (1980)
10.1007/BF00261406
Tumor uptake of 67Ga-carrying liposomes
I. Ogihara (2004)
10.1016/S0168-3659(01)00326-1
VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery.
S. Dagar (2001)
10.1158/1078-0432.CCR-05-1730
Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
Ja Kyung Kim (2006)
10.1148/RADIOLOGY.166.3.3340774
In-111-labeled liposomes: dosimetry and tumor depiction.
A. F. Turner (1988)
10.1016/J.ADDR.2004.01.011
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
A. Gabizon (2004)
10.1016/0378-5173(90)90047-8
Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants
S. Tröster (1990)
10.1007/BF02710168
Liposomal cytarabine (DepoCyte®) for the treatment of neoplastic meningitis
A. R. Domínguez (2005)
Induction of DNA double-strand breaks by ionizing radiation of different quality and their relevance for cell inactivation.
G. Kampf (1988)
10.1016/S0169-409X(02)00019-4
PEG-based micelles as carriers of contrast agents for different imaging modalities.
V. Torchilin (2002)
10.1208/pt070361
Formulation of anastrozole microparticles as biodegradable anticancer drug carriers
A. Zidan (2008)
10.3349/ymj.2005.46.1.51
Therapeutic Effects of Holmium-166 Chitosan Complex in Rat Brain Tumor Model
R. Huh (2005)
10.1016/0883-2897(91)90126-6
90Y-resin particles--animal experiments on pigs with regard to the introduction of superselective embolization therapy.
P. Schubiger (1991)
Polyethyleneglycol based micelles as carriers of therapeutic and diagnostic agents
V. Trubetskoy (1996)
10.1007/s11095-005-2594-7
Regional Radiochemotherapy Using In Situ Hydrogel
A. Azhdarinia (2005)
10.1016/0378-5173(86)90021-9
Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits
S. J. Douglas (1986)
The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors.
N. Ackerman (1969)
10.1016/S0090-8258(89)80040-X
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy.
J. Rotmensch (1989)
The treatment of cancer of the ovaries. Its improvement by intraperitoneal administration of radioactive colloidal gold
Muller Jh (1963)
Nuclear medicine : diagnosis and therapy
J. Harbert (1996)
Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
Stacy M Stephenson (2003)
10.2214/AJR.106.2.333
Perfusion I-131 macroaggregate brain scanning; a clinical evaluation of its diagnostic efficiency.
Santos Briz Kanafani (1969)
10.3109/02652049609026015
Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
S. C. Mehta (1996)
10.1046/J.1523-1747.2003.12057.X
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.
R. Kunstfeld (2003)
10.1002/(SICI)1097-4636(19981215)42:4<617::AID-JBM19>3.0.CO;2-4
Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy.
S. Conzone (1998)
10.1002/MRM.1910110211
A liposomal MRI contrast agent: Phosphatid ylethanolamine‐DTPA
C. Grant (1989)
10.1016/J.EJPB.2006.10.016
Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.
U. Häfeli (2007)
10.1002/ijc.11526
Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinase
M. Kondo (2004)
10.1016/S0142-9612(01)00055-2
Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate.
J. F. Nijsen (2001)
Measurement of splenic function with heat-damaged RBCs: effect of heating conditions: concise communication.
P. Valk (1984)
10.3748/WJG.V5.I6.492
Clinical and experimental study on regional administration of phosphorus 32 glass microspheres in treating hepatic carcinoma.
L. Liu (1999)
10.1007/BF02563897
Diagnostic angioscintigraphic evaluation of malignant hepatic tumors before catheter embolization: Determination of shunt, flow distribution, and reflux
R. Walser (2007)
10.1016/0883-2897(91)90104-S
A lipophilic complex with 186Re/188Re incorporated in liposomes suitable for radiotherapy.
U. Häfeli (1991)
Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field.
H. Kobeiter (2007)
10.1016/0378-5173(91)90089-7
Liposomes as carriers of 99m Tc glucoheptonate for liver imaging
M. Jaggi (1991)
10.1097/01.RVI.00001142592.89564.F9
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.
J. Goin (2005)
10.1016/S0304-3835(99)00388-2
Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.
H. Tokumitsu (2000)
10.3349/ymj.2005.46.6.799
A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma
B. Cho (2005)
The antihepatoma effect of lyophilized aclacinomycin A polyisobutylcyanoacrylate nanoparticles in vitro and in vivo
Jiang Xh (1995)
10.1097/00006231-199302000-00009
The feasibility of 225 Ac as a source of α‐particles in radioimmunotherapy
M. W. Geerlings (1993)
10.1016/J.BIOPHA.2005.05.011
Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
H. Yanagie (2006)
10.1016/S1535-6108(02)00238-6
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.
D. Hallahan (2003)
10.1038/bjc.1979.138
Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients.
V. J. Richardson (1979)
10.1016/0378-5173(95)04386-1
Development of amphiphilic diblock copolymers as micellar carriers of taxol
X. Zhang (1996)
10.1158/1535-7163.MCT-06-0264
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma
Tamantha K. Stutchbury (2007)
10.1067/MVA.2003.177
R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue.
V. Erzurum (2003)
10.1016/J.APRADISO.2005.08.003
Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy.
M. Mortensen (2006)
10.1007/BF01402256
Der Wert der Hirnszintigraphie mit MAA-J131 bei intraarterieller Injektion in die Arteria Carotis
B. Armenise (2005)
10.1016/S0939-6411(02)00085-1
Tumor accumulation of gadolinium in lipid-nanoparticles intravenously injected for neutron-capture therapy of cancer.
T. Watanabe (2002)
Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.
W. Yang (1997)
10.1053/J.GASTRO.2004.09.034
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
J. Geschwind (2004)
10.1016/S0169-409X(98)00108-2
Delivery of gamma-imaging agents by liposomes.
Phillips (1999)
10.1016/J.SOC.2007.03.002
Nanotechnology for sensing, imaging, and treating cancer.
B. Panchapakesan (2007)
10.1016/J.BBMT.2006.12.448
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
A. Christoforidou (2007)
10.1016/J.JCONREL.2004.07.019
Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.
I. Brigger (2004)
10.1016/S1076-6332(96)80448-X
Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging.
V. Trubetskoy (1996)
10.1148/RADIOLOGY.172.3.2549567
Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres.
S. Houle (1989)
10.1016/J.JCONREL.2006.05.030
A polymeric micelle MRI contrast agent with changeable relaxivity.
E. Nakamura (2006)
10.1016/J.EJPB.2007.04.003
Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intra-tumoral therapy.
M. Hamoudeh (2007)
Nuclear medicine approaches in the monitoring of thyroid cancer patients.
S. Sergieva (2006)
10.1016/S0169-409X(98)00110-0
Delivery of contrast agents for positron emission tomography imaging by liposomes.
Oku (1999)
10.1073/PNAS.89.19.9039
Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes.
K. Shelly (1992)
Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes.
X. Q. Pan (2002)
10.1002/jcb.10401
Combined vascular targeted imaging and therapy: A paradigm for personalized treatment
K. C. Li (2002)
10.1016/J.APRADISO.2005.01.001
A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine.
G. Wunderlich (2005)
10.1097/00006231-199701000-00005
Liposomal distribution in malignant glioma: possibilities for therapy.
A. Khalifa (1997)
10.1016/0268-960X(87)90021-X
The value of indium-labelled leucocytes in clinical practice.
A. Peters (1987)
10.1080/1061186021000054933
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
M. Videira (2002)
10.1016/J.JCONREL.2004.07.024
Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay.
L. Geng (2004)
10.1042/BST0050290
Properties of [99mTc] technetium-labelled liposomes in normal and tumour-bearing rats.
V. J. Richardson (1977)
10.1002/BIES.950131204
The role of DNA double strand breaks in lonizing radiation‐induced killing of eukaryotic cells
George Lliakis (1991)
10.1002/JBM.A.30076
Biodegradable radiation delivery system utilizing glass microspheres and ethylenediaminetetraacetate chelation therapy.
S. Conzone (2004)
10.1002/(SICI)1099-081X(199607)17:5<435::AID-BDD435>3.0.CO;2-K
In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography.
N. Oku (1996)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
Increased delivery of gallium-67 to tumors using serum-stable liposomes.
I. Ogihara-Umeda (1988)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1007/s00259-006-0139-x
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies
T. Elbayoumi (2006)
10.1016/J.NIMA.2006.08.124
Internal radiotherapy and dosimetric study for 111In/177Lu-pegylated liposomes conjugates in tumor-bearing mice
Hsin-Ell Wang (2006)
10.1016/S0076-6879(05)91008-2
Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
N. Oku (2005)
10.1021/CR030441B
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
10.1007/s00259-005-1859-z
Treatment of hepatocellular carcinoma by means of radiopharmaceuticals
B. Lambert (2005)
10.1016/S0969-8043(00)00313-4
Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation.
U. Häfeli (2001)
Use of technetium-99m-liposomes in tumor imaging.
B. Goins (1994)
10.1016/S0939-6411(99)00039-9
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
10.1016/S1076-6332(99)80063-4
CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles.
V. Torchilin (1999)
10.1016/J.JCONREL.2005.12.014
Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis.
A. Azab (2006)
10.1002/1097-0142(19880301)61:5<931::AID-CNCR2820610513>3.0.CO;2-4
Nonabsorbable radioactive material in the treatment of carcinomas by local injections
K. B. Nakhgevany (1988)
10.1002/1097-0142(19921101)70:9<2250::AID-CNCR2820700906>3.0.CO;2-4
A phase I dose escalation trial of yttrium‐90 microspheres in the treatment of primary hepatocellular carcinoma
F. Shepherd (1992)
10.1016/J.EJPB.2007.02.016
Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.
F. Tewes (2007)
Engineered Liposomes for Potential α-Particle Therapy of Metastatic Cancer
Stavroula Sofou (2004)
10.1002/1097-0142(19880901)62:5<905::AID-CNCR2820620509>3.0.CO;2-3
Successful imaging of human cancer with indium‐111‐labeled phospholipid vesicles
Cary A. Presant (1988)
10.2174/156720107780362294
Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy.
H. Ichikawa (2007)
10.1016/J.NUCMEDBIO.2003.11.004
Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclides
G. Henriksen (2004)
10.1159/000092935
Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer
H. G. van der Poel (2006)
10.1111/j.1572-0241.2007.01172.x
Gastroduodenal Injury After Radioembolization of Hepatic Tumors
C. Carretero (2007)
10.2349/biij.2.3.e43
Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
R. Murthy (2006)
10.2307/3578662
Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.
R. H. Larsen (1994)
10.1097/MNM.0B013E3280895E34
The role of FDG PET in the management of lymphoma: practical guidelines.
A. M. Kirby (2007)
Two ways to establish potential At-211 radiopharmaceuticals.
G. Wunderlich (1997)
10.1002/JBM.820280809
Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy.
U. Häfeli (1994)
10.1023/A:1018995124527
Chitosan-Gadopentetic Acid Complex Nanoparticles for Gadolinium Neutron-Capture Therapy of Cancer: Preparation by Novel Emulsion-Droplet Coalescence Technique and Characterization
H. Tokumitsu (2004)
Polymeric microspheres for radionuclide synovectomy containing neutron-activated holmium-166.
R. Mumper (1992)
10.1016/J.JMMM.2005.01.086
Synthesis of polyacrylamide modified magnetic nanoparticles and radiolabeling with 188Re for magnetically targeted radiotherapy
Chunfu Zhang (2005)
10.1016/J.IJPHARM.2003.03.002
Magnetically modulated therapeutic systems.
U. Häfeli (2004)
10.1248/CPB.37.1351
Liposomes prepared from synthetic amphiphiles. I. Their technetium labeling and stability.
R. Goto (1989)
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
K. Harrington (2001)
10.1088/0031-9155/48/10/305
Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases.
A. Syme (2003)
10.3109/08982109409018613
NEW APPROACHES IN THE CHEMICAL DESIGN OF Gd- CONTAINING LIPOSOMES FOR USE IN MAGNETIC RESONANCE IMAGING OF LYMPH NODES
V. Trubetskoy (1994)
Resonance enhanced neutron captures for element activation and waste transmutation
C. Rubbia (1997)
10.1016/0090-8258(92)90141-5
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
I. Vergote (1992)
10.1054/JCMS.2001.0234
Tumour embolization of the Vx2 rabbit head and neck cancer model with Dextran hydrogel and Holmium-poly(L-lactic acid) microspheres: a radionuclide and histological pilot study.
R. van Es (2001)
In-111-labeled platelet scintigraphies in patients with chronic hepatitis C.
S. Wang (2002)
10.1016/0883-2897(92)90136-M
Development of a liposome-encapsulated radionuclide with preferential tumor accumulation--the choice of radionuclide and chelating ligand.
I. Ogihara-Umeda (1992)
10.2174/187152007780618207
The bright future of radionuclides for cancer therapy.
J. F. Nijsen (2007)
10.1016/0969-8043(93)90068-L
Labelled polycyanoacrylate nanoparticles for human in vivo use.
G. Ghanem (1993)
10.1089/105072502320288465
Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
O. Konuk (2002)
10.1006/GYNO.1995.1093
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model.
R. Larsen (1995)
10.1002/(SICI)1097-0142(19981101)83:9<1894::AID-CNCR4>3.0.CO;2-O
Internal radiation therapy for patients with primary or metastatic hepatic cancer
S. Ho (1998)
10.1586/14737140.7.6.833
Nanotechnology for targeted cancer therapy
M. Wang (2007)
10.1016/S0378-5173(03)00132-7
A PEGylated dendritic nanoparticulate carrier of fluorouracil.
D. Bhadra (2003)
10.1016/0002-9378(89)90293-7
The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma.
J. Rotmensch (1989)
10.1016/J.IJPHARM.2006.02.039
Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection.
A. Bao (2006)
10.1007/S10856-007-3130-6
Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy
Sheng Liang (2007)
10.1046/j.1537-2995.1999.39299154728.x
Measurement of circulating red cell volume using biotin‐labeled red cells: validation against 51Cr‐labeled red cells
D. Mock (1999)
10.1042/BST0051380
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents: attempts to improve localization in tumour tissues [proceedings].
E. D. Neerunjun (1977)
10.3109/10611869709017895
Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography.
V. Trubetskoy (1997)
Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate.
D. K. Hughes (2003)
Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.
K. Harrington (2000)
10.1016/0360-3016(87)90168-4
Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton's lymphoma associated antigen (anti-DLAA).
M. Udayachander (1987)
Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas.
Backlund Eo (1989)
10.1002/lt.20001
Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis
R. Bellmann (2004)
10.1016/J.ADDR.2004.01.004
Folate-receptor-targeted radionuclide imaging agents.
Chun-Yen Ke (2004)
10.1023/A:1018953810705
Prolonged Systemic Delivery of Peptide Drugs by Long-Circulating Liposomes: Illustration with Vasopressin in the Brattleboro Rat
M. Woodle (2004)
10.1016/J.IJROBP.2006.02.061
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
R. Salem (2006)
10.1016/0883-2897(87)90047-X
Therapeutic use of 90Y microspheres.
G. Ehrhardt (1987)
10.3109/08982109909035546
LIPOSOMES AS CARRIERS OF RADIONUCLIDES: FROM IMAGING TO THERAPY
K. Kostarelos (1999)
Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals.
K. Kostarelos (2000)
Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation.
D. Hnatowich (1981)
Neutron-activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors.
R. Mumper (1991)
10.1021/OL062840+
Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
J. Lee (2007)
10.1023/A:1018908600711
Poly(L-lactic Acid) Microspheres Containing Neutron-Activatable Holmium-165: A Study of the Physical Characteristics of Microspheres Before and After Irradiation in a Nuclear Reactor
R. Mumper (2004)
10.1016/0969-8051(94)00124-3
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
U. Häfeli (1995)
10.1016/J.IJPHARM.2007.07.010
Dirhenium decacarbonyl-loaded PLLA nanoparticles: influence of neutron irradiation and preliminary in vivo administration by the TMT technique.
M. Hamoudeh (2008)
10.1021/BC980091D
Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
H. Kobayashi (1999)
10.1002/1097-0142(19880401)61:7<1336::AID-CNCR2820610711>3.0.CO;2-K
Effects of hepatic arterial yttrium 90 glass microspheres in dogs
I. Wollner (1988)
10.1016/J.JMMM.2003.10.022
Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy
Jinquan Cao (2004)
10.1267/NUKL04020063
[Therapy of malignant ascites in vivo by 211At-labelled microspheres].
J. Bredow (2004)
Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody.
D. Emfietzoglou (2005)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
Radionuclide therapy of cancer patients with bone metastases.
M. Yaneva (2005)
10.1016/J.IJROBP.2005.12.051
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
A. Kennedy (2006)
10.1038/bjc.1997.118
Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.
H. Yanagië (1997)
10.1097/00000658-196508000-00018
Treatment of Inoperable Primary Pancreatic and Liver Cancer by the Intra‐Arterial Administration of Radioactive Isotopes (Y Radiating Microspheres)
I. Ariel (1965)
10.1111/j.1600-0609.2004.00401.x
Imaging of central nervous system lymphomas with iodine‐123 labeled rituximab
M. Dietlein (2005)
Totally implanted drug delivery system for hepatic arterial chemotherapy.
W. Ensminger (1981)
Enhanced delivery of etoposide to Dalton's lymphoma in mice through polysorbate 20 micelles.
L. H. Reddy (2006)
[Estimation of the reticuloendothelial function by positron emission computed tomography (PET) study in chronic liver disease].
S. Okada (1990)
10.1021/BC00025A008
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy.
R. Barth (1994)
10.1097/00006231-199407000-00009
166Ho‐microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pig
J. Turner (1994)
10.1182/BLOOD-2005-11-4757
Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25.
Zhuo Zhang (2006)
10.1529/BIOPHYSJ.107.107417
Peptides and Gd complexes containing colloidal assemblies as tumor-specific contrast agents in MRI: physicochemical characterization.
M. Vaccaro (2007)
10.1007/BF00256940
Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors
I. Ogihara-Umeda (2004)
10.1016/J.IJROBP.2004.09.004
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
A. Kennedy (2004)
10.1016/J.JVS.2004.02.031
Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
M. Moon (2004)
10.1002/JBM.A.31183
Characterization of holmium loaded alginate microspheres for multimodality imaging and therapeutic applications.
S. W. Zielhuis (2007)
10.1016/J.IJPHARM.2005.10.010
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Donald E. Owens (2006)
10.1016/J.JCONREL.2007.03.012
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
P. Kocbek (2007)
10.1002/lt.20036
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients
B. Carr (2004)
Optimal radiolabeled liposomes for tumor imaging.
I. Ogihara-Umeda (1996)
10.1097/00004424-199512000-00005
Renal Pathology After Arterial Yttrium-90 Microsphere Administration in Pigs: A Model for Superselective Radioembolization Therapy
A. Zimmermann (1995)
10.1159/000100172
Stereotactic intracavitary irradiation of cystic craniopharyngiomas with yttrium-90 isotope.
Jenö Julow (2007)
Curative aim and results of routine intraperitoneal radiocolloid administration in the treatment of ovarian cancer.
Muller Jh (1963)
10.1080/026520499288834
Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine.
Â. Moraes (1999)
10.1016/J.APRADISO.2004.05.071
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Weilian Yang (2004)
The blood supply of neoplasms in the liver.
C. Breedis (1954)



This paper is referenced by
10.1016/j.brachy.2013.06.007
Praseodymium-142 microspheres for brachytherapy of nonresectable hepatic tumors.
M. Ferreira (2013)
10.15373/2249555X/JAN2014/16
Nanomedicines Targeting Cancer: Current Status and Future Prospects of the Therapeutic and Diagnostic Approaches
Foram Shukla (2011)
10.4172/2155-9619.1000390
Dendrimer Nanoparticles Conjugated 99mTC as a Promising Bioimaging Probe
H. Bagheri (2018)
10.2147/IJN.S28279
Correlation between radioactivity and chemotherapeutics of the 111In-VNB-liposome in pharmacokinetics and biodistribution in rats
W. Lee (2012)
10.1021/ACS.BIOMAC.6B00929
Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy.
Flonja Liko (2016)
10.1016/j.biomaterials.2010.07.048
Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
M. Roger (2010)
10.1016/j.ejps.2018.06.029
I‐131 doping of silver nanoparticles platform for tumor theranosis guided drug delivery
T. Sakr (2018)
10.1039/C2SM07320J
Facile preparation of coating fluorescent hollow mesoporous silica nanoparticles with pH-sensitive amphiphilic diblock copolymer for controlled drug release and cell imaging
X. Mei (2012)
10.3109/10717544.2011.635721
The use and importance of liposomes in Positron Emission Tomography
M. Silindir (2012)
10.1021/bc100018n
Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.
J. Seo (2010)
10.1016/j.molonc.2010.08.003
Targeted nanoagents for the detection of cancers
J. Mccarthy (2010)
10.1371/journal.pone.0164626
68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies
E. Verger (2016)
10.1155/2016/6148357
In Vivo Radionuclide Generators for Diagnostics and Therapy
Patricia E. Edem (2016)
10.1002/9781118229019.CH6
Targeted Nanoparticles in Radiotherapy
M. Muscarella (2012)
10.2147/IJN.S91008
Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma
Ying-Hsia Shih (2015)
Microspheres of polyester loaded with Holmium-165: effect of gamma irradiation on the polymeric structure
T. Piovan (2011)
10.1016/j.jcis.2009.02.035
Coating liposomes with yttrium basic carbonate: making hybrid nanocapsules.
M. G. Bellino (2009)
10.1533/9780857096357.1
The main health hazards from building materials
A. Fucic (2012)
10.1007/s11095-017-2320-2
Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging
M. de Souza Albernaz (2017)
10.1016/j.ceramint.2020.08.027
Fe3O4@Au/reduced graphene oxide nanostructures: Combinatorial effects of radiotherapy and photothermal therapy on oral squamous carcinoma KB cell line
Tahereh Shakerian Ardakani (2020)
10.1201/B14540-14
Nano/Microspheres in Bioimaging and Medical Diagnosis
Xiaohui Li (2013)
Electron microscopy studies on functional carbon nanotubes
E. Pach (2017)
10.1039/C1NJ20416E
Dendrimers in nuclear medical imaging
C. Ghobril (2012)
Preparation and characterisation of composite nanomaterials for radionuclide delivery
N. P. Juraj (2016)
10.2147/IJN.S118482
Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations
Fagner Santos do Carmo (2017)
10.1667/RR13664.1
Modeling Dose Deposition and DNA Damage Due to Low-Energy β– Emitters
D. Alloni (2014)
10.1021/ic202605z
Rhenium(V) and technetium(V) nitrido complexes with mixed tridentate π-donor and monodentate π-acceptor ligands.
A. Boschi (2012)
10.1007/s10534-008-9181-4
Imaging atoms in medicine
M. T. Albelda (2008)
MICROSPHERES OF POLYESTHER LOADED WITH HOLMIUM-165 : EFFECT OF GAMMA IRRADIATION ON THE POLYMERIC STRUTURE
T. Piovan (2011)
10.3390/molecules19010538
Pharmacokinetics of BMEDA after Intravenous Administration in Beagle Dogs
Chih-Hsien Chang (2014)
10.1557/JMR.2012.271
Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
H. Santos (2013)
10.1007/s10118-013-1242-7
188Re-labeled hyperbranched polysulfonamine as a robust tool for targeted cancer diagnosis and radioimmunotherapy
N. Li (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar